Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2010
10/27/2010EP2243539A2 Functionalized ionic liquids, and methods of use thereof
10/27/2010EP2242752A1 Imidazolyl biphenyl imidazoles as hepatitis c virus inhibitors
10/27/2010EP2242750A1 Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors
10/27/2010EP2242742A2 Organic compounds
10/27/2010EP2242359A1 Synthesis of resorcylic acid lactones useful as therapeutic agents
10/27/2010EP1742634B1 Polycyclic pyrimidines as potassium ion channel modulators
10/27/2010EP1658282B1 Novel chelating agents and chelates and their use
10/27/2010CN1984897B Light-emitting device material and light-emitting device
10/27/2010CN1678317B 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/27/2010CN101871931A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related therto
10/27/2010CN101870690A Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
10/27/2010CN101870684A Scutellarin aglycone derivative for treating vascular dementia and preparation method and application thereof
10/27/2010CN101869565A Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts
10/27/2010CN101052639B Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/26/2010US7820838 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
10/26/2010US7820819 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010US7820698 3,5-dichloro-pyridin-4-ylmethyl)-(3,4-dimethoxy-phenyl)-(4-fluoro-benzyl)-amine; treating diseases involving inflammation, such as asthma or arthritis, or diseases of the central nervous such as cognitive decline or memory loss
10/26/2010US7820694 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
10/26/2010US7820678 Pyrazinoylguanidine derivatives target the kidney; cardiovascular disease; for treating diseases characterized by too little liquid on mucosal surfaces, increase potency, reduced mucosal absorption, and slow dissociation; long half-life on mucosal surfaces
10/26/2010US7820675 Benzofuran compounds
10/26/2010US7820669 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2410594C Heterocyclic aminoalkylpyridine derivatives as psychopharmaceuticals
10/26/2010CA2353627C Picolinamide derivative and harmful organism control agent comprising said picolinamide derivative as active component
10/26/2010CA2293436C Imidazolyl-cyclic acetals as tnf inhibitors
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121046A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010WO2010121036A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010WO2010120910A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
10/21/2010WO2010119984A1 3-aryl or heteroaryl-substituted indole derivative
10/21/2010WO2010065877A9 Methods of treating an overweight or obese subject
10/21/2010WO2007144699A3 Process for the preparation of alfuzosin
10/21/2010US20100267965 3-Alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one Derivatives as Intermediates in the Synthesis of Renin Inhibitors
10/21/2010US20100267964 N-heterocyclylphenyl-substituted cyclic ketoenols
10/21/2010US20100267947 Exo-selective synthesis of himbacine analogs
10/21/2010US20100267946 Prodrugs of gaba analogs, compositions and uses thereof
10/21/2010US20100267945 Amine derivative having npy y5 receptor antagonistic activity
10/21/2010US20100267793 Method of treatment using n3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267776 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
10/21/2010US20100267771 Automated immunossay apparatus with flexible pick-up arm
10/21/2010US20100267759 INHIBITORS OF Akt ACTIVITY
10/21/2010US20100267755 Pyrimidine derivatives
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267710 N3 alkylated benzimidazole derivatives as mek inhibitors
10/21/2010US20100267698 Benzimidazole and Pyridylimidazole Derivatives
10/21/2010US20100267697 Ion channel modulators
10/21/2010US20100266621 Methods and systems for treating cell proliferation disorders with psoralen derivatives
10/21/2010US20100266570 Dimeric derivatives of artemisinin and application in anticancer therapy
10/21/2010CA2758934A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010CA2758929A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/20/2010EP2241565A1 Aurora kinase inhibitors compounds
10/20/2010EP2241560A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
10/20/2010EP2241559A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
10/20/2010EP2240471A1 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes
10/20/2010EP2240467A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
10/20/2010EP2240442A2 Preparation process useful in synthesis of atorvastatin
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2144897B1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/20/2010EP2102173B1 Pyrimidyl derivatives as protein kinase inhibitors
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868451A Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
10/20/2010CN101868448A 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
10/20/2010CN101863883A Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof
10/20/2010CN101863881A Synthetic method of polysubstituted furan drug molecule
10/20/2010CN101863877A Therapeutic agents useful for treating pain
10/20/2010CN101863846A Cis fluorine-containing 1,4-benzodiazepine*derivative and preparation method thereof
10/20/2010CN101863839A N-3-aramid-5-cyclopropane spiro hydantoin derivative, preparation method and application thereof
10/20/2010CN101863838A Method for synthesizing benzodiamine spiro-ring drug template
10/20/2010CN101863826A Method for preparing 2-benzyl pyridine compound
10/20/2010CN101863824A Synthesis method of chemical compound containing a dihydrogen ferrocenylmethyl-substituted indenes ketone and pyrrole skeleton
10/20/2010CN101863823A 2-oxindole compounds, and ring-enlargement derivatives, preparation method and application thereof
10/20/2010CN101862345A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
10/19/2010US7816539 Melanocortin receptor MC4 modulators; obesity, sexual disorders, anxiolytic agents, analgesics, antidepressants; 6-(aminomethyl)-2-aminobenzimidazole derivatives
10/19/2010US7816529 Sodium and calcium channel antagonists; higher potency; fewer side effects to central nervous system
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816378 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816361 such as 4-(5-Oxo-3-pyrazin-2-yl-2,5-dihydro-pyrazol-1-yl)-N-(1,2,2,6,6-pentamethyl-piperidin-4-yl)-benzamide, used as immunomodulators for the treatment of rheumatoid arthritis, psoriasis, multiple sclerosis and diabetes
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010US7816357 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2463284C Pyrimidine compounds and pharmaceutical compositions containing the compounds
10/19/2010CA2393158C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2271096C Trisresorcinyltriazines
10/14/2010WO2010118063A2 Therapeutic compositions and related methods of use
10/14/2010WO2010117977A1 Hepatitis c virus inhibitors
10/14/2010WO2010117932A1 Indole derivatives and methods for antiviral treatment
10/14/2010WO2010117635A1 Hepatitis c virus inhibitors
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010116915A1 Cyclic compound having substituted phenyl group
10/14/2010WO2010116248A1 Organic compounds and their uses
10/14/2010WO2010115548A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
1 ... 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 ... 694